EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Formulation and Systematic Optimisation of Polymeric Blend Nanoparticles via Box–Behnken Design

Basant Salah Mahmoud iD, Christopher McConville

Pharmaceutics · 20.10.2025 · 17 (10) · 1351

DOI: 10.3390/pharmaceutics17101351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 20.10.2025. Verfasst von Basant Salah Mahmoud und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian government of a PhD scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Despite the advantages of polycaprolactone (PCL) for drug delivery, it still lacks effective approaches to enhance its encapsulation of drugs. Blending PCL with less hydrophobic polymers can tailor physicochemical properties to overcome these limitations. This study, for the first time, integrates two beneficial approaches—polymer blending and Box–Behnken design (BBD) optimisation—to develop PCL-based blend nanoparticles (NPs) with enhanced encapsulation efficiency (EE), controlled particle size, and improved stability through surface charge modulation.

Methods

Drug-loaded blend NPs were developed using a double emulsion method, with different polymer ratios. A BBD model was employed to investigate the influential factors that control the size, charge, and EE.

Results

Blending PCL with a less hydrophobic polymer significantly improved EE, achieving 60.96% under optimal conditions. The BBD model successfully predicted conditions for obtaining NPs with optimum size, negative charge, and enhanced drug encapsulation. The drug amount was identified as the most influential factor for EE, while polymer amounts significantly impacted size and charge.

Conclusions

Careful control of polymer ratios, drug amount, and surfactant levels was shown to significantly influence particle size, surface charge, and EE, with the balanced 50:50 PCL:PLGA blend achieving optimal physicochemical performance. Using the BBD, the study identified the predicted optimal formulation consisting of 162 mg polymer blend, 8.37 mg drug, and 8% surfactant, which is expected to yield NPs with a size of 283.06 nm, zeta potential of −31.54 mV, and EE of 70%. The application of BBD allowed systematic evaluation of the factors and their interactions, providing robust predictive models.

Schlagwörter

Stichwörter der Autor:innen

Box–Behnken designencapsulation efficiencyirinotecan hydrochloridenanoparticlespolycaprolactonepolylactic-co-glycolic acidsizezeta potential

Autor:innen und Institutionen

  • School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK.
  • Hormones Department, Institute of Medical Research and Clinical Studies, National Research Centre, El Buhouth St., Dokki, Cairo 12622, Egypt.
  • Centre for Genomic Medicine, School of Biomedical Sciences, Ulster University, Coleraine BT52 1SA, UK.

ORCID-Profile: Basant Salah Mahmoud

Förderung

  • Egyptian government of a PhD scholarship

Zitieren

APA

Mahmoud, B. S., & McConville, C. (2025). Formulation and Systematic Optimisation of Polymeric Blend Nanoparticles via Box–Behnken Design. Pharmaceutics, 17(10), 1351. https://doi.org/10.3390/pharmaceutics17101351

Vancouver

Mahmoud BS, McConville C. Formulation and Systematic Optimisation of Polymeric Blend Nanoparticles via Box–Behnken Design. Pharmaceutics. 2025;17(10):1351. doi:10.3390/pharmaceutics17101351

BibTeX
@article{Mahmoud2025,
  author = {Mahmoud, Basant Salah and McConville, Christopher},
  title = {Formulation and Systematic Optimisation of Polymeric Blend Nanoparticles via Box–Behnken Design},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {10},
  pages = {1351},
  doi = {10.3390/pharmaceutics17101351}
}
Kostenlos starten →